Arkadios Wealth Advisors Immuno Gen, Inc. Transaction History

Arkadios Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$5.02 - $6.59 $10,567 - $13,871	-2,105 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$5.79 - $8.6 $4,226 - $6,278	730 Added 53.09%	2,105 $13,000
Q1 2021 Apr 26, 2021	BUY	$6.5 - $10.53 $7,052 - $11,425	1,085 Added 374.14%	1,375 $11,000
Q4 2020 Feb 09, 2021	BUY	$3.7 - $7.66 $1,073 - $2,221	290 New	290 $1,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.